These results indicate that commonly used prostate cancer cell lines recapitulate patterns of oncogenic ETS expression observed in tumors, such as a positive correlation between oncogenic ETS expression and PI3K/AKT pathway activation, and negative correlation between oncogenic ETS expression and RAS/ERK pathway mutations. The gene discussed is AKT1; the disease is prostate cancer.